Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume 37, Issue 1, Pages 143-153
Publisher
Springer Science and Business Media LLC
Online
2022-11-18
DOI
10.1038/s41375-022-01755-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MOLECULAR CHARACTERIZATION OF MUTANT TP53 ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME
- (2022) Tim Grob et al. BLOOD
- Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence
- (2021) Cihangir Duy et al. Cancer Discovery
- Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia
- (2021) Franck Rapaport et al. LEUKEMIA
- KAT6A and ENL Form an Epigenetic Transcriptional Control Module to Drive Critical Leukemogenic Gene-Expression Programs
- (2021) Fangxue Yan et al. Cancer Discovery
- Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
- (2020) Courtney D. DiNardo et al. BLOOD
- CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma
- (2020) Beatriz Salvador-Barbero et al. CANCER CELL
- Venetoclax plus LDAC for patients with untreated AML ineligible for intensive chemotherapy: phase 3 randomized placebo-controlled trial
- (2020) Andrew Henry Wei et al. BLOOD
- Distinct and overlapping mechanisms of resistance to azacytidine and guadecitabine in acute myeloid leukemia
- (2020) Emily Gruber et al. LEUKEMIA
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
- (2020) Courtney D. DiNardo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer therapy shapes the fitness landscape of clonal hematopoiesis
- (2020) Kelly L. Bolton et al. NATURE GENETICS
- The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
- (2020) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
- (2019) Sibylle Cocciardi et al. Nature Communications
- Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia
- (2019) Charles C. Bell et al. Nature Communications
- HBO1 is required for the maintenance of leukaemia stem cells
- (2019) Laura MacPherson et al. NATURE
- Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience
- (2018) Chezi Ganzel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
- (2018) Miriam Y. Kim et al. CELL
- CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
- (2018) Jeffrey E. Lancet et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Minimal Residual Disease in Acute Myeloid Leukemia
- (2018) Mojca Jongen-Lavrencic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth
- (2018) Jonathan B. Baell et al. NATURE
- The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation
- (2018) Natalia Martinez-Soria et al. CANCER CELL
- Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
- (2018) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
- (2017) Hamid Bolouri et al. NATURE MEDICINE
- Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies
- (2017) Nikolas Herold et al. NATURE MEDICINE
- Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6
- (2016) I. Z. Uras et al. BLOOD
- Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
- (2016) John G Doench et al. NATURE BIOTECHNOLOGY
- Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
- (2016) Sheng Li et al. NATURE MEDICINE
- SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
- (2016) Constanze Schneider et al. NATURE MEDICINE
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Implications of Genetic and Epigenetic Alterations of CDKN2A (p16 INK4a ) in Cancer
- (2016) Ran Zhao et al. EBioMedicine
- Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML
- (2016) Morito Kurata et al. Scientific Reports
- Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse
- (2015) M. Garg et al. BLOOD
- Requirement for CDK6 in MLL-rearranged acute myeloid leukemia
- (2014) T. Placke et al. BLOOD
- MLL fusion-driven activation ofCDK6potentiates proliferation inMLL-rearranged infant ALL
- (2014) Marieke Van der Linden et al. CELL CYCLE
- Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
- (2014) Dirk Heckl et al. NATURE BIOTECHNOLOGY
- Improved vectors and genome-wide libraries for CRISPR screening
- (2014) Neville E Sanjana et al. NATURE METHODS
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
- (2011) F. G. Rucker et al. BLOOD
- Cytarabine Dose for Acute Myeloid Leukemia
- (2011) Bob Löwenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia
- (2010) Michael G Kharas et al. NATURE MEDICINE
- Genetic factors influencing cytarabine therapy
- (2009) Jatinder K Lamba PHARMACOGENOMICS
- An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
- (2008) K. H. Metzeler et al. BLOOD
- Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
- (2008) R. G.W. Verhaak et al. HAEMATOLOGICA
- Highly parallel identification of essential genes in cancer cells
- (2008) B. Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started